Palazzolo et al. reported that IGF-1 could reduce androgen receptor (AR) aggregation and increase AR clearance in cells expressing AR65Q, a cell model of SBMA, a polyQ neurodegenerative disease. Here, AR is linked to neurodegenerative disease.